July 9, 2024 10:38 AM EDT
News Briefing

Kymer­a's stock ris­es af­ter der­ma in­ves­ti­ga­tion ex­pands; Lig­and buys Ape­iron

ENDPOINTS

Plus, news about AEON Bio­phar­ma, Mod­er­na and Mit­subishi Tan­abe:

Sanofi ex­pands der­ma­tol­ogy tri­als: Kymera Ther­a­peu­tics said that ex­pand­ing the Phase …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times